Elvina Almuradova/LinkedIn
Apr 29, 2025, 18:10
Elvina Almuradova: A new era in organ preservation
Elvina Almuradova, Ambassador at European School of Oncology, shared on X about recent paper by Andrea Cercek et al. published in New England Journal of Medicine:
“In early-stage dMMR cancers, neoadjuvant PD-1 blockade achieved 92% 2-year recurrence-free survival – many patients avoided surgery. A new era in organ preservation!”
Nonoperative Management of Mismatch Repair–Deficient Tumors
Authors: Andrea Cercek et al.
Read insight on OncoDaily to explore more about dMMR:
“Organ Preservation in dMMR Tumors: Results from Neoadjuvant Phase II Study with Dostarlimab”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 7, 2025, 21:02
Aug 7, 2025, 20:53
Aug 7, 2025, 19:57
Aug 7, 2025, 19:49